Related Experiment Video
Updated: May 4, 2026

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
Invasive micropapillary breast carcinoma: a retrospective study of classification by pathological parameters
E Mahe1, M Farag, O Boutross-Tadross
1University of Calgary, Faculty of Medicine, Department of Pathology & Laboratory Medicine, Calgary, AB, Canada.
Abstract:
Micropapillary breast carcinoma has been recognized as a morphologically and biologically distinct form of breast carcinoma. Although data suggest that patient outcomes in cases of micropapillary breast carcinoma do not differ significantly from other breast carcinomas, the impact that a micropapillary component might have on the pathological work-up of a case of breast carcinoma remains an important point of discussion (especially as pertaining to the risk of lymphovascular disease). In this study, we perform an extensive retrospective study of the pathological parameters of seven years of breast surgical pathology cases to explore the relationship that micropapillary morphology might have with other important pathological parameters of a breast cancer case work-up (e.g. tumour size, lymphovascular invasion, lymph node status). We also analyze our data set to see if a micropapillary component would influence hierarchical classification by pathological parameters. Micropapillary features correlated with a higher frequency of ER positivity and lymphovascular invasion; there was no statistical difference between those cases with and without a micropapillary component from the perspective of other clinicopathological parameters, however. The presence of micropapillary features did influence classification, however, and produced a distinct cluster amidst comparison of other pathological variables.
Insights
Micropapillary features in breast cancer correlate with estrogen receptor positivity and lymphovascular invasion. However, these features do not significantly alter overall patient outcomes or other clinicopathological parameters.
Area of Science:
- Oncology
- Pathology
- Breast Cancer Research
Background:
- Micropapillary breast carcinoma is a distinct subtype.
- Its impact on pathological work-up, particularly lymphovascular invasion risk, requires clarification.
- Patient outcomes may not differ significantly from other breast carcinomas.
Purpose of the Study:
- To investigate the relationship between micropapillary morphology and key pathological parameters in breast cancer.
- To explore the influence of micropapillary features on the hierarchical classification of breast cancer cases.
- To assess the correlation of micropapillary morphology with tumor size, lymphovascular invasion, and lymph node status.
Main Methods:
- Retrospective analysis of seven years of breast surgical pathology cases.
- Evaluation of pathological parameters including tumor size, lymphovascular invasion, and lymph node status.
- Statistical analysis to compare cases with and without micropapillary components.
Main Results:
- Micropapillary features showed a correlation with higher frequency of Estrogen Receptor (ER) positivity.
- Micropapillary morphology was associated with an increased incidence of lymphovascular invasion.
- No statistical difference was observed in other clinicopathological parameters between cases with and without micropapillary components.
Conclusions:
- Micropapillary features in breast cancer are linked to ER positivity and lymphovascular invasion.
- The presence of micropapillary features influences pathological classification, forming a distinct cluster.
- Micropapillary morphology impacts specific pathological parameters but not overall clinicopathological classification or patient outcomes.
More Related Videos
11:34Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
10:10Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms
Published on: April 17, 2026